SCHEMBL5533354

SCHEMBL5533354

C=C[CH]NNCC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5992718 1.00
SCHEMBL18412179 0.75
SCHEMBL277738 0.73
SCHEMBL251419 0.71
SCHEMBL1468276 0.71
SCHEMBL17224732 0.69
SCHEMBL45172 0.69
SCHEMBL3264437 0.67
SCHEMBL3502009 0.63
SCHEMBL2531231 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6956052-B2 Substituted pyrazolyl compounds for the treatment of inflammation PHARMACIA CORPORATION (US) 2005-10-18 US claimed
EP-3160594-A1 PERSONAL CARE COMPOSITIONS AND METHODS The Procter & Gamble Company (US) 2017-05-03 EP disclosed
WO-2016003948-A1 PERSONAL CARE COMPOSITIONS AND METHODS THE PROCTER & GAMBLE COMPANY (US) 2016-01-07 WO disclosed
US-20070270312-A1 Heteroaroyl-Substituted Serineamides BASF AKTIENGESELLSCHAFT (DE) 2007-11-22 US disclosed
EP-1292579-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE Pharmacia Corporation (US) 2003-03-19 EP disclosed
WO-2001087854-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL PYRAZINONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed
WO-2001087852-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL URACILS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-11-22 WO disclosed